Sign In

Login

Password

Forgot Password ? Sign Up

VLA2001 (German Wikipedia)

Analysis of information sources in references of the Wikipedia article "VLA2001" in German language version.

Last modified:

Ref.Un. Ref.Website
Global rank German rank
96europa.eu
62nd place
21st place
33valneva.com
low place
low place
32aerzteblatt.de
3,794th place
234th place
32doi.org
2nd place
3rd place
32nih.gov
5th place
7th place
32kurier.at
1,812th place
111th place
22clinicaltrials.gov
4,259th place
2,974th place
22apotheke-adhoc.de
low place
2,037th place
21gov.uk
401st place
812th place
21pharmazeutische-zeitung.de
low place
730th place
11reuters.com
38th place
126th place
11wallstreet-online.de
low place
2,058th place
11merkur.de
1,789th place
99th place
11finanzen.net
low place
731st place
11faz.net
282nd place
12th place
11web.archive.org
1st place
1st place
11redirecter.toolforge.org
29th place
2nd place
11deutsche-apotheker-zeitung.de
low place
1,049th place
11orf.at
386th place
17th place
11evaluate.com
low place
low place
11n-tv.de
1,358th place
74th place
11infranken.de
low place
827th place

aerzteblatt.de (Global: 3,794th place; German: 234th place)

apotheke-adhoc.de (Global: low place; German: 2,037th place)

clinicaltrials.gov (Global: 4,259th place; German: 2,974th place)

deutsche-apotheker-zeitung.de (Global: low place; German: 1,049th place)

doi.org (Global: 2nd place; German: 3rd place)

  • Cov-Boost-Studie nach 84 Tagen: X. Liu, A. P. Munro, S. Feng, L. Janani, P. K. Aley, G. Babbage, D. Baxter, M. Bula, K. Cathie, K. Chatterjee, W. Dejnirattisai, K. Dodd, Y. Enever, E. Qureshi, A. L. Goodman, C. A. Green, L. Harndahl, J. Haughney, A. Hicks, A. A. van der Klaauw, J. Kwok, V. Libri, M. J. Llewelyn, A. C. McGregor, A. M. Minassian, P. Moore, M. Mughal, Y. F. Mujadidi, K. Holliday, O. Osanlou, R. Osanlou, D. R. Owens, M. Pacurar, A. Palfreeman, D. Pan, T. Rampling, K. Regan, S. Saich, T. Serafimova, D. Saralaya, G. R. Screaton, S. Sharma, R. Sheridan, A. Sturdy, P. Supasa, E. C. Thomson, S. Todd, C. Twelves, R. C. Read, S. Charlton, B. Hallis, M. Ramsay, N. Andrews, T. Lambe, J. S. Nguyen-Van-Tam, V. Cornelius, M. D. Snape, S. N. Faust: Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK: Three month analyses of the COV-BOOST trial. In: The Journal of Infection, [elektronische Veröffentlichung vor dem Druck] April 2022; doi:10.1016/j.jinf.2022.04.018, PMID 35405168, PMC 8993491 (freier Volltext).
  • Cov-Boost-Studie nach 28 Tagen: A. P. Munro, L. Janani, V. Cornelius, P. K. Aley, G. Babbage, D. Baxter, M. Bula, K. Cathie, K. Chatterjee, K. Dodd, Y. Enever, K. Gokani, A. L. Goodman, C. A. Green, L. Harndahl, J. Haughney, A. Hicks, A. A. van der Klaauw, J. Kwok, T. Lambe, V. Libri, M. J. Llewelyn, A. C. McGregor, A. M. Minassian, P. Moore, M. Mughal, Y. F. Mujadidi, J. Murira, O. Osanlou, R. Osanlou, D. R. Owens, M. Pacurar, A. Palfreeman, D. Pan, T. Rampling, K. Regan, S. Saich, J. Salkeld, D. Saralaya, S. Sharma, R. Sheridan, A. Sturdy, E. C. Thomson, S. Todd, C. Twelves, R. C. Read, S. Charlton, B. Hallis, M. Ramsay, N. Andrews, J. S. Nguyen-Van-Tam, M. D. Snape, X. Liu, S. N. Faust: Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial. In: The Lancet, Dezember 2021, Band 398, Nummer 10318, S. 2258–2276; doi:10.1016/S0140-6736(21)02717-3, PMID 34863358, PMC 8639161 (freier Volltext).

europa.eu (Global: 62nd place; German: 21st place)

ema.europa.eu

ec.europa.eu

evaluate.com (Global: low place; German: low place)

faz.net (Global: 282nd place; German: 12th place)

finanzen.net (Global: low place; German: 731st place)

gov.uk (Global: 401st place; German: 812th place)

infranken.de (Global: low place; German: 827th place)

kurier.at (Global: 1,812th place; German: 111th place)

merkur.de (Global: 1,789th place; German: 99th place)

n-tv.de (Global: 1,358th place; German: 74th place)

nih.gov (Global: 5th place; German: 7th place)

ncbi.nlm.nih.gov

  • Cov-Boost-Studie nach 84 Tagen: X. Liu, A. P. Munro, S. Feng, L. Janani, P. K. Aley, G. Babbage, D. Baxter, M. Bula, K. Cathie, K. Chatterjee, W. Dejnirattisai, K. Dodd, Y. Enever, E. Qureshi, A. L. Goodman, C. A. Green, L. Harndahl, J. Haughney, A. Hicks, A. A. van der Klaauw, J. Kwok, V. Libri, M. J. Llewelyn, A. C. McGregor, A. M. Minassian, P. Moore, M. Mughal, Y. F. Mujadidi, K. Holliday, O. Osanlou, R. Osanlou, D. R. Owens, M. Pacurar, A. Palfreeman, D. Pan, T. Rampling, K. Regan, S. Saich, T. Serafimova, D. Saralaya, G. R. Screaton, S. Sharma, R. Sheridan, A. Sturdy, P. Supasa, E. C. Thomson, S. Todd, C. Twelves, R. C. Read, S. Charlton, B. Hallis, M. Ramsay, N. Andrews, T. Lambe, J. S. Nguyen-Van-Tam, V. Cornelius, M. D. Snape, S. N. Faust: Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK: Three month analyses of the COV-BOOST trial. In: The Journal of Infection, [elektronische Veröffentlichung vor dem Druck] April 2022; doi:10.1016/j.jinf.2022.04.018, PMID 35405168, PMC 8993491 (freier Volltext).
  • Cov-Boost-Studie nach 28 Tagen: A. P. Munro, L. Janani, V. Cornelius, P. K. Aley, G. Babbage, D. Baxter, M. Bula, K. Cathie, K. Chatterjee, K. Dodd, Y. Enever, K. Gokani, A. L. Goodman, C. A. Green, L. Harndahl, J. Haughney, A. Hicks, A. A. van der Klaauw, J. Kwok, T. Lambe, V. Libri, M. J. Llewelyn, A. C. McGregor, A. M. Minassian, P. Moore, M. Mughal, Y. F. Mujadidi, J. Murira, O. Osanlou, R. Osanlou, D. R. Owens, M. Pacurar, A. Palfreeman, D. Pan, T. Rampling, K. Regan, S. Saich, J. Salkeld, D. Saralaya, S. Sharma, R. Sheridan, A. Sturdy, E. C. Thomson, S. Todd, C. Twelves, R. C. Read, S. Charlton, B. Hallis, M. Ramsay, N. Andrews, J. S. Nguyen-Van-Tam, M. D. Snape, X. Liu, S. N. Faust: Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial. In: The Lancet, Dezember 2021, Band 398, Nummer 10318, S. 2258–2276; doi:10.1016/S0140-6736(21)02717-3, PMID 34863358, PMC 8639161 (freier Volltext).

orf.at (Global: 386th place; German: 17th place)

wien.orf.at

pharmazeutische-zeitung.de (Global: low place; German: 730th place)

redirecter.toolforge.org (Global: 29th place; German: 2nd place)

reuters.com (Global: 38th place; German: 126th place)

valneva.com (Global: low place; German: low place)

wallstreet-online.de (Global: low place; German: 2,058th place)

web.archive.org (Global: 1st place; German: 1st place)